Otorhinolaryngologic Diseases

65 trials 30 recruiting

Filter these 65 trials by phase, country and sponsor.

Open in Search →

Evaluation of the Efficacy of 3-month Continuous Extended Treatment With Azithromycin in Idiopathic Purulent Oedematous Sinusitis in Adults:… Ended

2024-517239-33-00 Ear, nose and throat diseases 5 2022-10-06
A prospective, randomised, multi-centre, double-blind, placebo-controlled Phase III trial to investigate the efficacy and safety of lozenges… Halted

2025-521764-35-01 acute pharyngitis 5 2026-01-27
Open-label, randomized, two-period, two-treatment, two-sequence, crossover, balanced, study to assess the bioequivalence between the test pr… Ended

2025-522971-27-00 Bioequivalence study under fasting conditions 2 2025-10-20
A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity Ended

2024-513679-42-00 Obesity 4 2025-04-09
Characterisation and intervention study in patients with long-term use of nasal decongestants. Ended

2024-516312-25-00 rhinitis medicamentosa 6 2024-09-05
Effect of Dupilumab on nasal epithelial barrier function in patients with Chronic Rhinosinusitis with nasal polyps (CRSwNP) – an exploratory… Ended

2023-509815-10-00 Chronic rhinosinusitis with nasal polyps 6 2024-05-15
Radiotherapy plus xevinapant or placebo in older patients with locally advanced head and neck cancer Ended

2022-502339-20-00 Squamous cell carcinoma of head and neck 4 2023-11-15
A phase IV, randomized double blinded placebo-controlled study on the barrier restoring capacity of Dupilumab in type 2 airway disease: CRSw… Ended

2023-504014-30-00 chronic rhinosinusitis with nasal polyps 6 2023-11-14
Safety, tolerability, and efficacy of ACOU085 for prevention of hearing loss in testicular cancer patients receiving cisplatin Ended

2023-503696-15-00 sensorineural hearing loss (SNHL) 4 2023-11-10
Treatment of non-type 2 CRSwNP with anti-IL-17 antibody (secukinumab) Ended

2023-505711-20-00 Chronic rhinosinusitis with nasal polyps 6 2023-08-13
Multicentric randomized phase I/IIa trial of the safety and immunogenicity of a therapeutic HPV DC targeting vaccine in patients with Human … Ended

2022-502930-25-00 reduced risk of relapse of HPV-related oropharyngeal sq 7 2023-07-31
A Single Dose, Fast State, Bioequivalence Study of CEFIXIMA ATB 400 mg Hard Capsules (Antibiotice S.A.) vs. CEFIXORAL® 400 mg Film Coated Ta… Ended

2023-504011-33-00 healthy subjects 2 2023-06-12
SENS-401 to Prevent the Ototoxicity induced by Cisplatin in Adult Subjects with a Neoplastic Disease Ended

2024-511713-38-00 Cisplatine induced hearing loss 4 2022-12-30
Patient reported efficacy of intranasal lysine-aspirin in controlling NSAID-exacerbated respiratory disease. Ended

2024-517437-40-00 Nonsteroidal anti-inflammatory drug Exacerbated Respira 4 2022-11-15
A Study to Evaluate the Efficacy, Safety and Tolerability of a Single Injection of AC102 into the Middle Ear Compared to Oral Steroid Treatm… Ended

2024-513658-31-00 Idiopathic Sudden Sensorineural Hearing Loss 4 2022-08-08
Hyperbaric OXygen therapy for ACute Acoustic Trauma; HOXACAT Ended

2024-517739-35-00 Acute acoustic trauma 5
Phase II study evaluating peptide-based immunotherapies as monotherapy for 3 weeks prior to standard treatment for head and neck cancer. Ended

2024-513447-82-00 squamous cell carcinoma of the head and neck 4